A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Oedema in Patients With Malignant Brain Tumour Who Require Chronic Administration of High-Dose Dexamethasone

Trial Profile

A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Oedema in Patients With Malignant Brain Tumour Who Require Chronic Administration of High-Dose Dexamethasone

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2014

At a glance

  • Drugs Corticorelin (Primary)
  • Indications Brain oedema
  • Focus Registrational; Therapeutic Use
  • Sponsors Celtic Pharma
  • Most Recent Events

    • 10 Apr 2014 New trial record
    • 10 Apr 2014 New trial record
    • 06 Mar 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top